Please login to the form below

Not currently logged in
Email:
Password:

business model

This page shows the latest business model news and features for those working in and with pharma, biotech and healthcare.

Malthus’ orphans

Malthus’ orphans

Professor Brian D Smith is an authority on the pharmaceutical industry and works at SDA Bocconi University and Hertfordshire Business School. ... But, to adapt Richard Feynman’s famous quote, for a successful business model, reality must take

Latest news

  • The call for a more strategic medical affairs community The call for a more strategic medical affairs community

    This strengthening drive towards ‘patient-centricity’means Medical Affairs finds itself at the heart of pharma’s new business model.

  • Getting the sizing right Getting the sizing right

    Professor Brian D Smith is an authority on the pharmaceutical industry and works at SDA Bocconi University and Hertfordshire Business School. ... In a nutshell, size is good but simply upscaling the current business model won’t work.

  • Bayer looks to leverage AI across the pharma value chain Bayer looks to leverage AI across the pharma value chain

    Fear has become a business model. “But when there is no trust and no certainty, what can we base our decisions on?

  • Digital shakeout Digital shakeout

    Professor Brian D Smith is an authority on the pharmaceutical industry and works at SDA Bocconi University and Hertfordshire Business School. ... Equally, models that don’t do this are disfavoured by the business environment.

  • The secret of success The secret of success

    How does this relate to the business models of life science companies and the current crop of financial results? ... When you try to manage them as one business model, they conflict with each other.

More from news
Approximately 1 fully matching, plus 230 partially matching documents found.

Latest Intelligence

  • How can pharma build bridges with HCPs online? How can pharma build bridges with HCPs online?

    This business model not only enables precise, secure and compliant engagement of staff within their workplace, it also delivers a revenue share back to the NHS trusts.

  • Deal Watch January 2018

    Spin-outs don't always last long as independent companies. In our recent annual deal review for 2017 we highlighted how the spin-out business model is alive and kicking and

  • A marathon and a sprint A marathon and a sprint

    One year earlier Gartner forecast that, by 2018, half of all organisations would have implemented significant business model changes to improve their customer experience. ... Brand communication is owned by commercial and is cascaded through the business.

  • Warning signs Warning signs

    If pharma continues its myopic focus on a prescriber-led business model it will end up being too late to a party where Apple and the likes already own the right ... And so the message is clear: the pharmaceutical industry’s future business model will

  • Boosting pharma’s metabolic rate Boosting pharma’s metabolic rate

    Biopharma company UCB is a good example of an organisation that has made patient-centricity a reality at the core of the business. ... The established business model is not equipping the leaders of the future with the skills they will need to negotiate

More from intelligence
Approximately 0 fully matching, plus 38 partially matching documents found.

Latest appointments

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    Brooksby brings experience in business and growth strategy across the healthcare sector having held senior global positions at Pfizer, Sanofi and Wellcome - now GSK. ... Brooksby said: “My focus is to accelerate the business model and drive commercial

  • Rainer Boehm and Hervé Hoppenot join Cellectics board Rainer Boehm and Hervé Hoppenot join Cellectics board

    Boehm spent 29 years serving Novartis working in various senior management, marketing, sales, and medical affairs roles, and his expertise spans from leadership and development to business model solutions. ... oncology and head of the US oncology

  • Novocure’s chief commercial officer to step down Novocure’s chief commercial officer to step down

    During his tenure, Peter developed our commercial business model, launched the Optune brand and drove eight consecutive quarters of active patient and revenue growth after the presentation of our EF-14

  • Galenica Group strengthens management team Galenica Group strengthens management team

    We opted for these variant because of the excellent knowledge Stefan Schulze brings to further developing the business model of Vifor Pharma.”. ... Santé. Burkhard joined the Galenica Group in 1996 as corporate controller of Galenica, taking

  • Moderna Therapeutics appoints chief business officer Moderna Therapeutics appoints chief business officer

    Moderna Therapeutics appoints chief business officer. Saqib Islam brings experience from Alexion Pharmaceuticals. ... Islam said: “ Already a clinical stage company, Moderna has extraordinary opportunities ahead of it, with its breakthrough science,

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

  • Digital trends in B2B sales - how far behind is Pharma?

    Even when they’ re shopping for their business, they expect an experience like B2C.”. ... ATKearney states that “ despite being an information-intensive industry, healthcare’ s business model has remained strangely unaffected by the digital

  • Is the pharma business model ready for precision medicine?

    Is the pharma business model ready for precision medicine? Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? ... As an organisation, Blue Latitude Health has built its business on this

  • How do you define a biotech company?

    The operational model deployed to build a business around this technology, the patient and the people who support them (carers, HCPs etc). ... The core values and culture driving the business and the people within it.

  • Patient Centricity: Turning Rhetoric into Reality

    As patients become increasingly involved in their own health and healthcare systems demand more evidence of outcomes, pharmaceutical organisations have been moving towards a business model that puts patients at the ... However is this transformation

  • Are reverse auctions the best way to procure marketing services?

    I have to be honest that at the time, Fred Bassett and I were working with Robbie Williams and his managers developing a new strategy and business model for music artists,

More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics